Ocado Group plc (OCDDY)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 1, 2024	Dec 3, 2023	Nov 27, 2022	Nov 28, 2021	Nov 29, 2020
Market Capitalization	4,003	3,295	6,160	6,402	18,046	21,804
Market Cap Growth	-40.55%	-46.51%	-3.77%	-64.53%	-17.24%	82.24%
Enterprise Value	5,421	4,856	7,370	7,467	17,919	21,575
Last Close Price	9.69	7.99	15.44	15.69	48.82	60.00
PE Ratio	7.04	-	-	-	-	-
PS Ratio	2.30	2.14	4.33	2.10	5.42	7.02
PB Ratio	1.70	2.22	3.22	2.74	7.93	8.92
P/TBV Ratio	2.75	4.89	5.60	4.09	12.34	10.72
P/FCF Ratio	16.61	35.98	-	-	-	-
P/OCF Ratio	8.69	9.65	59.13	670.41	-	72.58
EV/Sales Ratio	3.10	3.15	5.18	2.46	5.39	6.94
EV/EBITDA Ratio	28.53	39.37	93.63	-	-	-
EV/FCF Ratio	22.50	53.02	-	-	-	-
Debt / Equity Ratio	1.03	1.45	1.30	0.99	1.07	0.77
Debt / EBITDA Ratio	12.43	13.50	20.12	-	34.96	44.75
Debt / FCF Ratio	10.04	23.56	-	-	-	-
Asset Turnover	0.30	0.28	0.24	0.55	0.60	0.74
Inventory Turnover	12.28	13.03	8.75	27.18	21.08	26.90
Quick Ratio	1.95	1.05	2.19	2.61	3.84	3.80
Current Ratio	2.09	1.88	2.49	2.92	4.04	4.83
Return on Equity (ROE)	-24.09%	-25.32%	-15.25%	-26.42%	-10.48%	-5.39%
Return on Assets (ROA)	-2.77%	-3.56%	-3.09%	-6.18%	-2.62%	-1.81%
Return on Capital (ROIC)	-3.50%	-4.82%	-3.91%	-7.70%	-3.24%	-2.33%
Earnings Yield	14.20%	-12.96%	-6.46%	-8.60%	-1.65%	-0.82%
FCF Yield	6.02%	2.78%	-5.13%	-12.10%	-4.24%	-0.73%
Buyback Yield / Dilution	-0.66%	-0.44%	-5.64%	-4.52%	-2.99%	-3.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.